Slavin S, Morecki S, Weigensberg M, Bar S, Weiss L
Transplantation. 1986 Jun;41(6):680-7. doi: 10.1097/00007890-198606000-00003.
Allogeneic bone marrow (BM) chimeras induced by infusion of BM cells into recipients conditioned with total lymphoid irradiation (TLI) were shown to develop humoral and cell-mediated tolerance to host and donor-type alloantigens by a number of in vitro and in vivo assays. Spleen cells of tolerant chimeras exhibited suppressive activity of mixed lymphocyte reaction (MLR). MLR suppression was not abrogated by depletion of Lyt-2 cells, and neither could Lyt-2-positive cells sorted from the spleens of tolerant chimeras suppress MLR or attenuate graft-versus-host reactivity in vivo. Likewise, specifically unresponsive spleen cells obtained from chimeras could not be induced to respond in MLR against tolerizing host-type cells following depletion of Lyt-2 or passage through a nylon-wool column. Tolerance of chimera spleen cells to host alloantigens, best documented by permanent survival of donor-type skin allografts, could be adoptively transferred into syngeneic recipients treated by heavy irradiation but not into untreated or mildly irradiated recipients. Adoptive transfer of tolerance seemed to be associated with experimental conditions favoring engraftment of tolerant cells rather than suppression of host reactivity. We speculate that although host and/or donor-derived suppressor cells may be operating in reducing the pool of specific alloreactive clones by blocking cell proliferation in response to allogeneic challenge, the final outcome in tolerant chimeras is actual or functional deletion of alloreactive clones.
通过向接受全身淋巴照射(TLI)预处理的受体输注骨髓细胞诱导产生的同种异体骨髓嵌合体,经多项体外和体内试验表明,对宿主和供体型同种异体抗原产生了体液和细胞介导的耐受性。耐受嵌合体的脾细胞表现出混合淋巴细胞反应(MLR)的抑制活性。Lyt-2细胞的耗竭并未消除MLR抑制,从耐受嵌合体脾脏中分选的Lyt-2阳性细胞在体内也无法抑制MLR或减弱移植物抗宿主反应性。同样,从嵌合体获得的特异性无反应脾细胞在Lyt-2耗竭或通过尼龙毛柱后,也无法被诱导在MLR中对耐受宿主型细胞作出反应。嵌合体脾细胞对宿主同种异体抗原的耐受性,通过供体型皮肤同种异体移植物的长期存活得到了最好的证明,可以被过继转移到接受大剂量照射的同基因受体中,但不能转移到未处理或轻度照射的受体中。耐受性的过继转移似乎与有利于耐受细胞植入的实验条件有关,而不是与宿主反应性的抑制有关。我们推测,尽管宿主和/或供体来源的抑制细胞可能通过在同种异体刺激下阻断细胞增殖来减少特异性同种异体反应性克隆的数量,但耐受嵌合体的最终结果是同种异体反应性克隆的实际或功能性缺失。